Der p 1‐specific regulatory T‐cell response during house dust mite allergen immunotherapy
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Background: Allergen‐specific immunotherapy (AIT) is the only available treatment for allergic diseases that can induce specific immune tolerance to allergens. The key mechanisms involved in this process include changes in allergen‐specific regulatory T (Treg) cells. Methods: We studied 25 allergic rhinitis patients undergoing subcutaneous house dust mite–specific immunotherapy. Peripheral blood mononuclear cells were studied before and after 10, 30 weeks, and 3 years of AIT. Der p 1‐specific T regulatory cell responses were investigated by characterization of Der p 1‐MHC class II tetramer–positive cells and correlated with nasal symptom score. Results: Twelve of 25 AIT patients matched with their MHC class II expression to the Der p 1 peptide‐MHC class II tetramers. A significant increase in the numbers of Der p 1‐specific FOXP 3+Helios+CD 25+CD 127− Treg cells after 30 weeks was observed, which slightly decreased after 3 years of AIT. In contrast, Der p 1‐specific immunoglobulin‐like transcript 3 (ILT 3)+CD 25+ Treg cells decreased substantially from baseline after 3 years of AIT. ILT 3+ Treg cells displayed compromised suppressive function and low FOXP 3 expression. In addition, Der p 1‐specific IL‐10 and IL‐22 responses have increased after 30 weeks, but only IL‐10+ Der p 1‐specific Treg cells remained present at high frequency after 3 years of AIT. Increased number of FOXP 3+Helios+ and IL‐10+ and decreased ILT 3+ Treg cell responses correlated with improved allergic symptoms. Conclusion: The results indicate that AIT involves upregulation of the activated allergen‐specific Treg cells and downregulation of dysfunctional allergen‐specific Treg cell subset. Correction of dysregulated Treg cells responses during AIT is associated with improved clinical response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Thornton, A. M., Korty, P. E., Tran, D. Q., Wohlfert, E. A., Murray, P. E., Belkaid, Y., & Shevach, E. M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0904028 · Cited by 1,382
Nograles, K. E., Zaba, L. C., Shemer, A., Fuentes-Duculan, J., Cardinale, I., Kikuchi, T., Ramon, M., Bergman, R., Krueger, J. G., & Guttman-Yassky, E. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.03.041 · Cited by 627 · cited 1×
“However, an uncontrolled output of IL‐22 may lead to inflammation that has been observed in several diseases including atopic dermatitis, psoriasis, or rheumatoid arthritis.(54) IL‐22 is a member of the IL‐10 cytokine family but is usually detected in Th17 cells together with the production of IL‐ 17 and type 3 innate…”
BackgroundHelios Expression Is a Marker of T Cell Activation and Proliferation
Akimova, T., Beier, U. H., Wang, L., Levine, M. H., & Hancock, W. W. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024226 · Cited by 389 · cited 2×
“The same immunological events are also observed in the development of a healthy immune response to high dose of exposure of allergens in nonallergic individuals.17,21 Helios is a marker of T‐cell activation and proliferation, and Helios enhances induced Treg (iTreg) cell function in cooperation with FOXP3.”
BackgroundAdvances in allergen immunotherapy: Aiming for complete tolerance to allergens
Akdis, C. A., & Akdis, M. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa7390 · Cited by 118
Helios, and not FoxP3, is the marker of activated Tregs expressing GARP/LAP
Elkord, E., Abd Al Samid, M., & Chaudhary, B. (2015) · Oncotarget · doi:10.18632/oncotarget.4771 · Cited by 94 · cited 3×
“Combining FOXP3 and Helios intracellular staining is apparently a useful approach to determine activated Treg cells, because FOXP3Helios Treg cells proliferate in vitro significantly less than FOXP3Helios Tregs upon TCR stimulation.(43) Unlike FOXP3Helios Tregs, FOXP3Helios Tregs secrete IL‐10, but not other effector…”
BackgroundInfluential
Cited by
Akdis (2020) · doi:10.1111/pai.13189 · Cited by 320
Advances and highlights in allergic rhinitis
Zhang, Y., Lan, F., & Zhang, L. (2021) · Allergy · doi:10.1111/all.15044 · Cited by 282
Mechanisms of Allergen-Specific Immunotherapy and Allergen Tolerance
Kucuksezer, U. C., Ozdemir, C., Cevhertas, L., Ogulur, I., Akdis, M., & Akdis, C. A. (2020) · Allergology International · doi:10.1016/j.alit.2020.08.002 · Cited by 173
Self-citationFood Allergy and Intolerance: A Narrative Review on Nutritional Concerns
Gargano, D., Appanna, R., Santonicola, A., De Bartolomeis, F., Stellato, C., Cianferoni, A., Casolaro, V., & Iovino, P. (2021) · Nutrients · doi:10.3390/nu13051638 · Cited by 169
Metadata
- Authors
- Boonpiyathad, T., Sokolowska, M., Morita, H., Rückert, B., Kast, J. I., Wawrzyniak, M., Sangasapaviliya, A., Pradubpongsa, P., Fuengthong, R., Thantiworasit, P., Sirivichayakul, S., Kwok, W. W., Ruxrungtham, K., Akdis, M., & Akdis, C. A.
- Venue
- Allergy
- Publisher
- Wiley
- Published
- 2019-01-13
- Volume
- 74
- Issue
- 5
- Pages
- 976-985
- ISSN
- 0105-4538 (ISSN-L)
- 1398-9995
- OpenAlex
- W2903295289
- Cited by
- 93
- References
- 5
- FWCI
- 7.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Der p 1‐specific regulatory T‐cell response during house dust mite allergen immunotherapy. https://app.cochat.ai/papers/10.1111/all.13684
- The paper
- Boonpiyathad, T., Sokolowska, M., Morita, H., Rückert, B., Kast, J. I., Wawrzyniak, M., Sangasapaviliya, A., Pradubpongsa, P., Fuengthong, R., Thantiworasit, P., Sirivichayakul, S., Kwok, W. W., Ruxrungtham, K., Akdis, M., & Akdis, C. A. (2019). Der p 1‐specific regulatory T‐cell response during house dust mite allergen immunotherapy. Allergy. https://doi.org/10.1111/all.13684
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.